Gujarat Themis Biosyn Incorporates Japan Wholly-Owned Subsidiary

Gujarat Themis Biosyn incorporated a wholly owned subsidiary, Themis Biosyn Japan Limited, on May 19, 2026.
The new subsidiary has an authorized share capital of ¥1,000,000 and operates in the pharmaceutical industry.
The disclosure is made pursuant to SEBI Listing Regulations Regulation 30 and the January 2026 Master Circular.
The company holds 100% of the subsidiary's shareholding, and no governmental approvals were required for the incorporation.